Actually, Say Yes
to Dope
SCIENTIFIC KENYON

A Much-Maligned Drug
May be the Key to
Saving the Brain
from Concussions
by Charles Adams

I

n what was supposed to
be the prime of his career,
Calvin Johnson walked away
from the sport he loved. While hard
work and talent made him one of
the most prolific wide receivers in
the history of the National Football
League (NFL), the years of physical
abuse took a toll on his body, and
his brain. His team, the Detroit
Lions, and the NFL seemed unable
or unwilling to properly assist
Johnson in managing the damage
and the pain. So, he turned to one
particular compound after every
game, which he claims helped
him play for as long as he did. As
he confessed to Sports Illustrated,
“I had my preferred choice of
medicine. Cannabis.” Cannabis
allowed Johnson to continue to
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play, and it enabled Johnson to
walk away early but mostly whole.1
Johnson certainly suffered his
fair share of injuries over his nineyear career, from fingers pointing
the wrong direction to having at
least nine concussions.1 He needed
some way to recuperate, but he
found limited viable options. He
argues that smoking cannabis was
much better than the treatments
that he typically saw in the team
training room.
“When I got to the league,
[there] was opioid abuse,’ Johnson
says. ‘You really could go in the
training room and get what you
wanted. I can get Vicodin, I can get
Oxy[contin].It was too available. I
used Percocet and stuff like that.
And I did not like the way that

made me feel.”1
Recent evidence suggests that
the retired player might have been
on to something, especially in the
context of concussions and other
traumatic brain injuries (TBIs).
Since retiring, Johnson has
become a significant advocate of
the use of marijuana for medical
purposes.1 He is not alone. Players
around the NFL are jumping on the
cannabis bandwagon, along with
athletes across the professional
sports world. Megan Rapinoe, one
of the world’s highest profile female
athletes and member of the United
States’ Women’s National Soccer
Team, is a vocal proponent of
cannabidiol (CBD) treatment.2 CBD
is one of the major components
of marijuana and the subject of
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many promising clinical studies.
Having suffered multiple severe
knee injuries throughout her career,
Rapinoe believes that CBD helped
with the injury recovery process
and with managing pain.2 If so
many athletes tout the restorative
properties of the compound, why
is it that cannabis and CBD are
not widespread treatments? Well,
as most people know, cannabis
has been demonized for decades,
making its use illegal and scientific
research nearly impossible.

Sorry Not Sorry: A
Little Bit of History
Before getting into the
promising research regarding the
medical use of marijuana, and,
more specifically, CBD, it would be
beneficial to go into a brief history
of the drug. This will help elucidate
the factors that led to many of the
policies we see today, including
the recently ended NFL practice
of suspending players who tested
positive for marijuana.2 Cannabis
is one of the oldest plants to be
cultivated for non-food purposes,
dating as far back as cultures in
China in 4000 B.C. In ancient Asian
societies, people used the plant
to treat a multitude of ailments,
including
snakebites,
malaria,
gastrointestinal illness, pain from
childbirth, and seizures. Hinduism,
Buddhism, and other religious
groups included cannabis in their
ceremonies. Gradually, the plant
spread throughout Asia, the Middle
East, and eventually, Europe.
People also used the plant as a
fiber (for making cloth, paper, and
rope), oil, and intoxicating agent.3
In
the
mid-1500s,
the
Spanish introduced cannabis to
the Americas, where it was first
grown for manufacturing rope for
the navy. Eventually, it became a
staple of the American colonies
alongside tobacco.3 Its popularity
as a medical and recreational agent

continued to steadily grow until
the early 20th century, when the
Pure Food and Drug Act of 1906
and the Harrison Narcotic Act of
1914 placed constraints on its use
and sale.3,4 These restrictions were
not completely effective, however,
as there was another spike in use
when the Eighteenth Amendment
(1920) prohibited the consumption
of alcohol.3
There are many elements that
went into the initial demonization
of the compound. One of the
major factors was the association
of
marijuana
with
Mexican

immigrants.3,4 Xenophobic feelings
towards this group translated to a
hatred of the compound.4 Persistent
media attacks against cannabis led
to the Marijuana Tax Act of 1937,
which effectively stopped legal use.
The federal government was heavily
involved in this propaganda as the
first commissioner of the Federal
Narcotics Bureau, Harry Anslinger,
was the mastermind behind many
of these dramatic media assaults.
This
stigmatization
continued
to 1970 when the Controlled
Substances Act classified marijuana
as a Schedule I drug. Cannabis

“Pot Opens The Door” by Michelle Lynne. Available under CC0
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Molecular structure of THC and CBD. Original image by Charles Adams. Created in BioRender.

was one of the many compounds
that were ‘fought’ during the War
on Drugs.3 Negative propaganda
was (and continues to be, albeit
to a lesser extent) rampant. For
example, there was a repeated
weakly-based claim that marijuana
is a ‘gateway’ drug that would
lead to further use of harder, more
dangerous compounds. Many of the
illustrations and visuals employed
in anti-marijuana campaigns were
intentionally shocking or unsettling.
Today, despite a swing in
public opinion and the advent
of
new
research
indicating
the potential benefits of the
compound, cannabis remains a
Schedule I drug. This classification
is typically reserved for the most
dangerous compounds.
The
federal government categorizes
substances as such because the
compounds have no currently
accepted medical use, have a
23

high potential for abuse, and
create severe psychological and/
or physical dependence. Other
Schedule I drugs include heroine
and lysergic acid diethylamide
(LSD).
According
to
the
government’s classification system,
marijuana is more dangerous than
cocaine, methamphetamine (meth),
and fentanyl, all of which fall under
the Schedule II designation. As
such, cannabis is federally outlawed
for both medical and recreational
use.5 This can and has inhibited
research of the compound. CBD is
not technically prohibited federally,
but it is still derived from an illicit
substance, so attempts to perform
research on the molecule can be
complicated.

Marijuana: A
Complex Compound
When I first started researching

cannabis and its potential role for
treating TBIs, I considered the
drug to be a one-trick pony. The
only part of the plant that I had
ever really heard much about was
the primary active molecule, Δ-9tetrahydrocannabinol (THC). THC
is responsible for the majority of the
‘high’ that is felt as a result of taking
the drug.6 There are, however,
many more compounds found
within marijuana, including CBD.
Both THC and CBD fall under the
cannabinoid molecule family.6,7 This
means, despite small differences in
the structure, the main backbone
of the two molecules is shared.
These small variations in structure,
however, make a huge difference in
how our body reacts to them.
Behaviorally, THC exposure
induces
anxiety,
sedation,
dysphoria (a state of unease or
generalized dissatisfaction with
life), psychotic symptoms, and
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intoxication.
These symptoms
are
heavily
subjective
from
person to person.6 Alternatively,
CBD’s only behavioral impact is
sedation. In fact, something that
I find remarkably interesting is
that CBD seems to block some of
the effects of THC. Many of the
anxiety and psychosis-like effects
are significantly diminished when
CBD is taken at the same time as
THC.7 Marijuana has curious effects
on people, and I think that further
research should explore how each
molecule in the substance interacts
with the body.
While THC and CBD are the
main actors found, they make
up only a small portion of the
overall cannabis plant. The exact
percentages vary widely from
plant to plant and have been
changing throughout years, but the
National Institute on Drug Abuse
reports that the average percent
of cannabis that is THC and CBD
is 15.61 and 0.27, respectively (as
of 2018).8 This chemical makeup is
the result of a decades-long trend
that has seen THC steadily go up
in concentration. In 1995, the

average amount was 3.96%. CBD
has fluctuated throughout these
years, with a 1995 concentration
of 0.28% and its peak coming in
2001 at 0.55%.8 These patterns
are interesting considering the
aforementioned
interactions
between the two molecules. The
rest of the plant consists of hundreds
of other molecules. Over 60 of
these are additional cannabinoids
such as cannabinol (CBN) and
tetrahydrocannabivarin
(THCV).9
While we will be looking at recent
studies specifically concerning CBD
as a candidate for treating TBIs,
marijuana is extremely complex
and all of its molecular components
may be of interest to us, regardless
of how “minimal” their effects may
seem.

The Not-asFun Version of
Headbanging
Calvin Johnson and other
football players are not the only
people who have experienced
TBI. Everyone has hit their head

at one point in their lives. There
are a multitude of dangers for
our brains in our everyday lives,
whether it is a ball on the soccer
field, a car accident, or a lowhanging ceiling on a stairway. After
an incident, more often than not,
we rub our noggin and walk away.
Sometimes we experience a slight
feeling of embarrassment if we did
something particularly clumsy. We
all know major head injuries have
lasting consequences, but what can
be shocking to most is how little it
takes for long-term detrimental
brain effects to occur.
In 2013, a study indicated that
a significant portion of individuals
who experienced a single traumatic
brain injury were at an increased
likelihood to exhibit symptoms
of dementia and Alzheimer’s
disease.
Symptoms included
neuroinflammation (increase in
the inflammatory response in the
brain) and neurodegeneration
(deterioration of the brain and
nervous system). The presence
of extensive and densely packed
activated microglia (the brain’s
frontline immune defense cells)

Graph of the concentration of THC and CBD in marijuana from 1995-2018. Figure adapted from ‘Marijuana Potency,’ by the National Institute of Drug
Abuse, 2020, retrieved from https://www.drugabuse.gov/drug-topics/marijuana/marijuana-potency8. Available under public domain.
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within brain tissue served as an
indicator of this neuroinflammatory
response. This pattern of reactive
microglia was exhibited in over
a quarter of cases in which the
subject survived more than a year
after the initial trauma. Sometimes,
they were still present in cases up to
18 years later.10 This is a long time
after just one injury and speaks to
how important it is to find potential
long-term treatments.
In the same study, the
researchers found the injuries
people endured led to a decrease
in overall white matter integrity in
the brain for many subjects. Since
the tissue makes up a majority of
brain mass and plays a pivotal
role in the transmission of brain
signals, white matter is a crucial
component of the nervous system.
The effect was most pronounced in
cases where the elevated microglia
response was also present. This
leads to questions regarding the
relationship between an extended
neuroinflammatory
response
and long-term brain health. The
scientists also observed a 25%
reduction in the overall thickness
of the corpus callosum, a portion
of white matter that connects the
left and right sides of the brain and
is known to be heavily affected by
trauma in the average one-year
post-injury subject.10 These are
scary results, especially considering
there are those who experience
more than one TBI during their
lifetime. Research into potential
solutions is crucial for these people.

National CTE League
Sports can be punishing on the
body, especially high-contact sports
like football. High speed collisions
between players are in the very
nature of the game and occur on
every single play. For too many of
these athletes, concussions (a form
of TBI) are a way of life. It therefore
makes sense that the body of the
football athlete deteriorates more
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distinctly and rapidly than normal.
There are long-term consequences
for participating in such a violent
sport, especially for your brain and
central nervous system.
The long-term brain health
outcomes for football players are
not good, to put it mildly. Research
has indicated that the vast majority
of these athletes develop chronic
traumatic encephalopathy (CTE).
CTE is a neurodegenerative
disorder that is associated with
people who have experienced
TBIs. It is often correlated with
dementia and symptoms like
difficulty thinking, memory loss,
and an increase in aggressive and
depressive behaviors. Results of
one study concluded that, in a
sample of 202 deceased players
across all levels of competition,
CTE could be diagnosed in 87%
of cases. The numbers are even
more disheartening for former
NFL players. Over 99% (110 of
the 111) of these athletes showed
CTE pathology. One, one, person’s
brain did not show signs of the
condition.11 Granted, these brains
were donated to research for the
purpose of looking at brain health,
so there may be the confounding
variable that the donors suspected
they might have an issue. However,
99% is still 99% no matter how you
look at it.
Football players, although
likely the most well-known sufferers,
are not the only ones that have to
deal with CTE. Anyone who has
experienced multiple concussions
(diagnosed or undetected), are
at an increased likelihood of
developing the condition. These
include people who have been in
multiple car accidents and people
who have served in the military.10
In 2014 alone, the CDC reported
that there were about 2.87 million
TBI-related emergency department
visits, hospitalizations, and deaths
in the United States.12 CTE is a
disease that could potentially affect

millions of people. There is a clear
problem and there are few viable
options for treatment.
Unfortunately, many of the
physiological indicators required to
diagnose CTE are only discovered
after death. These markers include
the aforementioned decrease in
white matter volume and increase
in inflammation in the brain.10 On
a more molecular level, an effective
gauge for the progression of the
disease is the concentration of
hyperphosphorylated tau protein
aggregates (HTPA, sometimes
referred to as phosphorylated tau
immunoreactive
neurofibrillary
tangles, but I will stick with HTPA).13
HTPA are abnormal accumulations
of naturally occurring proteins. In
healthy cells, these tau proteins
are involved in the assembly and
stabilization of microtubules, which
are basic structural components
of the nervous system.14 When
they are hyperphosphorylated
(extra phosphate group molecules
are added to the basic structural
makeup of the protein) this causes
HTPA to form, leading to numerous
unwanted consequences. HTPA
are a hallmark of other related
neurological
conditions,
like
Alzheimer’s disease, generally
known as tauopathies.15 The specific
molecular composition of HTPA
varies depending on the condition,
but they are usually related in

Original image by Charles Adams. Created in
BioRender.
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general structure. Regardless of
ailment, higher concentrations of
HTPA are correlated with higher
severity disease states.15,16 Although
there is an apparent lack in truly
effective treatments for these
tauopathies, there is promising
research revolving around the use
of CBD, especially concerning its
use in alleviating the long-term
neurodegenerative effects of CTE.

CBD: A Rising Star
We all have that one friend
who will not stop talking about the
various vitamins and supplements
that they take. They tout the
wondrous things the vitamins
do for their health and how the
supplements ‘make them feel
years younger’.
Usually these
‘wonder’ remedies are little more
than placebos at best, and actively
detrimental to your health at worst.
Recently, one of these supplements
that seems to be hooking peoples’
attention is CBD.
The only
difference is CBD might actually
have the science to back it up.
Numerous recent studies
have supported the use of the
drug as a treatment for several
different ailments and diseases.
A 2012 study indicated that, in
lieu of the typical treatment for
schizophrenia, a routine CBD dose
helped alleviate subjects’ psychotic
symptoms.17
In another arena,
work in rats suggests that CBD can
prevent inflammation and thus,
pain and nerve damage associated
with osteoarthritis.18 Of course,
there is always the worry that a
potentially effective treatment will
pair badly with existing medication,
but preliminary evidence seems
to suggest that this might not be
the case for CBD. Research with
mice found that CBD inhibited
chemotherapy-induced
pain
without diminishing chemotherapy
effectiveness or otherwise reducing
the function of the nervous system.
In fact, in some cases, researchers

CBD prevents TBI-induced neurodegeneration. In normal mice, microtubules (blue bar) are stabilized by tau proteins (pink strands), and the mice will struggle when suspended upside down. In
mice that suffer a TBI, microtubules will fall apart (gray bar) as tau proteins become less effective.
This also leads to HTPA (pink tangle) in the brain and a lack of struggle in the mice when suspended
(they are more depressed). When treated with CBD, mice with TBI do not experience these detrimental neurological effects. Original image by Charles Adams. Created in BioRender.

found an increase in the efficacy of
the chemotherapy when paired with
CBD treatment.19 These are good
signs for the future therapeutic role
of this molecule and more studies
should definitely be performed.

An Extra Layer of
Padding
There are promising results
concerning CBD and its use to
fight against CTE. CBD might be
an effective combatant against
HTPA. A study found that PC12
cell cultures (representative of rat
neuronal brain cells), when treated
with CBD, show a decrease in the
HTPA formation due to β-amyloid
stimulation. β-amyloid stimulation
is what causes the tauopathy
patterns found in Alzheimer’s
disease.20 This is a really exciting

finding for all tauopathy treatment
research, not just with Alzheimer’s,
because the molecular markers of
these conditions are related.15,16
Since CBD can help prevent
HTPA in one disease, then there
is a chance that it can be used in
the fight against other related
disorders. More research is needed
to see if CBD can prevent the HTPA
connected with CTE.
CBD may help with the
negative behavioral aspects of CTE
as well.
Depression, increased
feelings of pain, and aggression are
all characteristic of the behavioral
profile of many pre- and postretirement contact sport athletes,
like football players.21,22 In a 2019
study involving a mouse model of
mild TBI, researchers found that
CBD treatment alleviated many of
these symptoms and more. TBI26
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induced mice acquired chronic
pain and exhibited aggressive,
depressive, and anxious behaviors.
The combination of these factors
probably led to the observed
decrease in the sociability of these
animals. When regularly treated
with CBD after they received their
TBI, these characteristics did not
develop.23 These are unbelievably
exciting results, and I cannot wait
for more related research to come
out.
You may be wondering how
in the world someone can do
research on subjective feelings,
like depression, in animals, and
you would not be in the wrong to
question the validity of the results.
It is difficult to understand just how
mice and rats are feeling, as they
do not usually speak any English,
but there are some methods that
are employed as stand-ins for trips
to the psychiatrist. For instance,
in the experiment mentioned
above, the scientists suspended
the mice upside down by their
tail and they measured how long
the mice remained still during a
set period of time. Immobility
is considered “giving up” and
a measure of hopelessness (a
symptom of depression) in mice. In
this study, control animals who did
not receive treatment were still for
a longer period of time than their
CBD medicated counterparts. This
means that the non-CBD treated
mice should be considered more
‘depressed.’ It also means that CBD
helped prevent neurobehavioral
degeneration after TBI.23 These
findings are extremely encouraging,
and I think that CBD treatment
should be further explored in this
arena.
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Hold On: There Are
No Cure-Alls Here
To produce many of the
wonderful studies and discoveries
regarding CBD, much of the
research was conducted with
animals. While they are immensely
helpful and can lead to many great
breakthroughs, animal studies are
no substitutes for human trials.
Many promising animal studies in
the past have not translated well
to people. The results we do have
are promising, but there is a limited
number of studies in humans on the
effects of CBD treatment. While
anecdotal evidence may seem
appealing, more experimentation is
needed before it can be definitively
stated that CBD is a miracle drug
that heals all bumps and bruises.
It should also be noted and
made clear that I am not advocating
for the use of marijuana. I am
merely a major supporter of the
study of the molecules that are
found within the substance. The
compound is still a drug. The
component parts may not be as
dangerous as the component
parts of other drugs, but they
should still be administered with
caution. For instance, smoking is
still smoking, and no matter what,
there are inevitable health-related
consequences of the practice.
Laws and rules on the use of the
drug and the molecules cultivated
from it vary from state to state and
organization to organization, so
proper knowledge on how the use
marijuana and CBD will affect your
legal life is always good information
to have.
It is also worth reminding you
that CBD, while not technically
federally prohibited, is derived
from a Schedule 1 substance in
the United States. Setting aside
the serious socio-economic effects
marijuana-related laws have had on
the country and the people who
live within it, this classification has

and continues to make research
difficult.
Laws may be more
lenient depending on the area of
the country in which you live, but
it makes receiving federal funding
a lot harder for anything related
to marijuana. These difficulties
are
especially
disheartening
considering all of the encouraging
TBI- and other health-related
findings regarding the compound.

A High Time for
Change
I love the game of football.
I deeply appreciate the sense
of community it brings and the
opportunities and chances it
provides for thousands of people
who would not have had anything
else. I also am grateful for all of the
sacrifices that veterans and activeduty military personnel have made
to keep us safe. These people
should not be forced to suffer for
the rest of their lives just because
they wanted to make ours better.
CTE and other brain disorders are
devastating, and their prevalence
is a problem that affects millions
of people. I believe that every
avenue should be explored when
trying to find a solution. One of
these potential paths involves the
much ostracized and demonized
drug cannabis and the molecule
CBD that is found within it. There
are promising preliminary results
regarding the compound and
molecule and I think that they
should be studied further.
Calvin Johnson walked away
from the sport he loved in order
to survive.
Controlled use of
medically researched CBD could
have extended his career while
maintaining his quality of life.
Whether it be football players,
people in the military, or any other
victims of TBI, everyone deserves
a chance at living a healthy and
happy life. Marijuana may provide
this chance.
■
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